Curegarden is a brand owned by Livlong Nutraceuticals Limited, which is a sister company of Arjuna Natural Limited is partnering with Langoor Havas.

Langoor Havas a part of the Havas CX network and has acquired the digital transform command for Curegarden, a pioneer in the science-based natural health supplements market and a brand owned by Livlong Nutraceuticals Limited, a sister organization of Arjuna Natural Limited.

Venugopal Ganganna, Chief Executive Officer, Langoor Havas, said, “Indian Nutraceuticals market is assumed to develop to $18 billion by 2025, as customers become more health and fitness conscious.

Amid the pandemic, ‘immunity’ has become a new buzzword, and the need for nutraceuticals beyond the world has developed manifold. While the world is battling with COVID-19, Curegarden is set out to promote its customer’s growth immunity and better health. We are delighted to partner with Curegarden in its dream of sharing a happier and healthier point of life with its consumers.”

Antony Kunjachan, CEO of CureGarden, said, “At Curegarden, our principal focus is to promote safe and effective Nature-based Nutraceutical formulations to obtain the advantages of Natural healthy living broadly accessible across India. We got a perfect partner in Langoor Havas to ideate and used our products to market, leveraging all things digital. We look forward to carrying this journey to new pitches.”


The information contained in this article is for educational and informational purposes only and is not intended as a health advice. We would ask you to consult a qualified professional or medical expert to gain additional knowledge before you choose to consume any product or perform any exercise.


Paayel is a correspondent at Sportz Business Magazine and pursuing Journalism from Lady Shri Ram college. She is an aspiring and passionate journalist, who is on her way to gain more knowledge and wisdom.

Write A Comment

4 × 1 =


By navigating our site, you agree to allow us to use cookies, in accordance with our Privacy Policy.